Key result
Minimalist TAVR enables moderate sedation and next-day discharge in lower-risk patients.
Why the study?
The field of transcatheter aortic valve replacement (TAVR) has undergone significant advancement over the past two decades through technological innovation, procedural refinement, and expansion to lower-risk populations and new indications.
This review highlights the evolution of TAVR into a streamlined, minimalist procedure performed under moderate sedation with next-day discharge, driven by technological advances, multidisciplinary heart team assessment, and expansion into lower-risk and novel aortic stenosis indications.
TAVR next-day discharge is feasible with sedation; leaves open optimal patient selection and outcome durability.
Over the past two decades, the field of transcatheter aortic valve replacement (TAVR) has undergone significant advancement, driven by both technological innovation and procedural refinement. Once a procedure that was conducted under general anesthesia in an operating room followed by a 5+-day hospital stay is now predominantly being done using moderate sedation in a catheterization laboratory, with many patients being discharged home the following day. Several factors have contributed to this transformation. These include the expansion of TAVR to lower-risk patient populations, reductions in delivery system size facilitating broader use of transfemoral access, and the implementation of streamlined care pathways such as the 3M approach—multidisciplinary, multimodality, but minimalist. This minimalist strategy has been pivotal in enhancing procedural efficiency and reducing resource utilization without compromising outcomes. As a result, TAVR volumes have grown exponentially in recent years and are expected to continue rising, particularly as the procedure is investigated for new indications such as moderate aortic stenosis and asymptomatic severe aortic stenosis. Central to the success of TAVR is a comprehensive assessment of each patient’s suitability for valve replacement, performed by a multidisciplinary heart valve team. Key Wards: Aortic stenosis, transcatheter aortic valve replacement, current situation.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2026) conducted a review in Aortic stenosis. Transcatheter aortic valve replacement (TAVR) was evaluated. Transcatheter aortic valve replacement has evolved over two decades from general anesthesia with a 5+-day hospital stay to moderate sedation with next-day discharge in lower-risk populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: